title: Potential role of natural killer cell receptor-expressing cells in immunotherapy for leukemia.
abstract: Natural killer cell receptor (NKR)-expressing cells have cytolytic activity against leukemic cells, and solid tumor cells escape from T-cell recognition because of the low expression levels of class I HLA molecules in both allogeneic and autologous settings. This characteristic feature of NK cell recognition of target cells in contrast with that of T-cells provides a strategy to overcome tolerance in the tumor-bearing host. Furthermore, inhibitory NKR-expressing cells may have cytolytic activity and immunoregulatory functions. Several methods can be used to expand NKR-expressing cells for adoptive immunotherapy for leukemia and other malignant diseases. We review recent developments in the biology and clinical application of NKR-expressing cells, such as NK cells, lymphokine-activated killer cells, cytokine-induced killer cells, NKT cells, and other NKR-expressing cells.
authors.affiliation: Hematology and Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. jutanaka@med.hokudai.ac.jp
authors.forename: Junji
authors.initials: J
authors.lastname: Tanaka
authors.forename: Masahiro
authors.initials: M
authors.lastname: Asaka
authors.forename: Masahiro
authors.initials: M
authors.lastname: Imamura
mesh_terms: D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D007694:Killer Cells, Natural / Q000276:immunology*; D007938:Leukemia / Q000276:immunology* / Q000628:therapy*
references.citation: J Immunol. 2002 May 15;168(10):4864-70
references.pmid: 11994435
references.citation: Eur J Immunol. 2003 Jul;33(7):2033-43
references.pmid: 12884870
references.citation: Transplantation. 2004 Jul 15;78(1):1-6
references.pmid: 15257030
references.citation: Int J Hematol. 2003 Oct;78(3):188-94
references.pmid: 14604276
references.citation: Br J Haematol. 2003 Jul;122(2):231-9
references.pmid: 12846891
references.citation: J Exp Med. 1998 Mar 2;187(5):813-8
references.pmid: 9480992
references.citation: N Engl J Med. 1998 Oct 22;339(17):1177-85
references.pmid: 9780337
references.citation: Cancer Immunol Immunother. 2003 Sep;52(9):525-34
references.pmid: 14627124
references.citation: Br J Haematol. 1998 Mar;100(4):655-63
references.pmid: 9531330
references.citation: Adv Immunol. 2000;74:181-273
references.pmid: 10605607
references.citation: Cancer Immunol Immunother. 1998 Aug;46(6):318-26
references.pmid: 9756416
references.citation: Eur J Immunol. 2003 Dec;33(12):3439-47
references.pmid: 14635054
references.citation: J Immunol. 2003 Oct 1;171(7):3442-50
references.pmid: 14500639
references.citation: Blood. 2002 Sep 15;100(6):1935-47
references.pmid: 12200350
references.citation: Immunity. 1999 Mar;10(3):281-7
references.pmid: 10204484
references.citation: Clin Cancer Res. 2002 Sep;8(9):2812-9
references.pmid: 12231521
references.citation: Blood. 2003 Aug 1;102(3):814-9
references.pmid: 12689936
references.citation: Nature. 2000 Jan 20;403(6767):325-8
references.pmid: 10659853
references.citation: J Immunol. 2004 Jan 1;172(1):644-50
references.pmid: 14688377
references.citation: Acta Haematol. 2001;105(2):89-91
references.pmid: 11408710
references.citation: Nat Immunol. 2001 Mar;2(3):255-60
references.pmid: 11224526
references.citation: Nature. 1998 Feb 19;391(6669):795-9
references.pmid: 9486650
references.citation: Blood. 2004 Aug 1;104(3):768-74
references.pmid: 15073036
references.citation: Blood. 2004 Feb 15;103(4):1521-6
references.pmid: 14504099
references.citation: Immunity. 1999 May;10(5):585-94
references.pmid: 10367904
references.citation: Hum Immunol. 2002 Mar;63(3):200-10
references.pmid: 11872238
references.citation: Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12000-4
references.pmid: 8265660
references.citation: Adv Immunol. 2000;76:1-60
references.pmid: 11079097
references.citation: Science. 1999 Jul 30;285(5428):730-2
references.pmid: 10426994
references.citation: Adv Exp Med Biol. 1998;452:13-8
references.pmid: 9889954
references.citation: Blood. 2001 May 15;97(10):3132-7
references.pmid: 11342440
references.citation: Bone Marrow Transplant. 2000 Aug;26(3):287-90
references.pmid: 10967567
references.citation: Blood. 1998 Nov 1;92(9):3318-27
references.pmid: 9787169
references.citation: Blood. 2004 Jul 1;104(1):170-7
references.pmid: 15016654
references.citation: Int J Hematol. 2003 Jul;78(1):1-6
references.pmid: 12894844
references.citation: Br J Haematol. 2000 Mar;108(4):778-83
references.pmid: 10792283
references.citation: Cancer. 1997 Jul 1;80(1):42-9
references.pmid: 9210707
references.citation: Immunol Rev. 2001 Jun;181:185-92
references.pmid: 11513139
references.citation: Adv Cancer Res. 1995;67:155-95
references.pmid: 8571814
references.citation: Nat Rev Immunol. 2003 Oct;3(10):781-90
references.pmid: 14523385
references.citation: Eur J Immunol. 2001 Apr;31(4):1076-86
references.pmid: 11298332
references.citation: J Clin Immunol. 2002 May;22(3):131-6
references.pmid: 12078854
references.citation: Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11328-33
references.pmid: 12167676
references.citation: Blood. 2004 Apr 15;103(8):3122-30
references.pmid: 15070694
references.citation: Int J Hematol. 2003 Jul;78(1):7-17
references.pmid: 12894845
references.citation: Blood. 2003 Mar 1;101(5):2024-32
references.pmid: 12406908
references.citation: Science. 1997 Nov 28;278(5343):1626-9
references.pmid: 9374463
references.citation: Cancer Immunol Immunother. 2004 Oct;53(10):879-92
references.pmid: 15338206
references.citation: Blood. 2002 Nov 15;100(10):3825-7
references.pmid: 12393440
references.citation: Science. 2002 Mar 15;295(5562):2097-100
references.pmid: 11896281
references.citation: Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8088-92
references.pmid: 9223319
references.citation: Blood. 1999 Jul 1;94(1):333-9
references.pmid: 10381530
references.citation: Nature. 2001 Sep 13;413(6852):165-71
references.pmid: 11557981
references.citation: Blood. 1997 Mar 1;89(5):1818-23
references.pmid: 9057668
references.citation: Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12433-8
references.pmid: 8901599
references.citation: J Immunother. 2001 Jul-Aug;24(4):363-73
references.pmid: 11565838
references.citation: Immunol Rev. 1998 Jun;163:197-215
references.pmid: 9700512
references.citation: J Immunol. 2001 Sep 15;167(6):3129-38
references.pmid: 11544298
references.citation: Br J Haematol. 2002 Jun;117(3):751-4
references.pmid: 12028053
references.citation: J Immunol. 1992 Nov 1;149(9):2945-53
references.pmid: 1401923
references.citation: Immunol Today. 1990 Jul;11(7):237-44
references.pmid: 2201309
references.citation: Blood. 2003 Aug 15;102(4):1389-96
references.pmid: 12714493
references.citation: Science. 1995 Apr 21;268(5209):403-5
references.pmid: 7716542
references.citation: J Clin Oncol. 2004 Mar 15;22(6):1136-51
references.pmid: 15020616
references.citation: Immunity. 2001 Feb;14(2):123-33
references.pmid: 11239445
references.citation: Science. 2002 Oct 25;298(5594):850-4
references.pmid: 12242449
references.citation: Blood. 1996 May 1;87(9):3993-4000
references.pmid: 8611732
references.citation: Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10896-901
references.pmid: 12960383
references.citation: Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1172-7
references.pmid: 9448304
references.citation: J Exp Med. 1996 Feb 1;183(2):645-50
references.pmid: 8627176
references.citation: Blood. 1999 Oct 1;94(7):2396-402
references.pmid: 10498612
references.citation: Nature. 2002 Oct 17;419(6908):734-8
references.pmid: 12384702
references.citation: N Engl J Med. 1987 Apr 9;316(15):889-97
references.pmid: 3493432
references.citation: Immunity. 2004 Sep;21(3):357-66
references.pmid: 15357947
references.citation: Science. 1999 Jul 30;285(5428):727-9
references.pmid: 10426993
references.citation: Immunol Rev. 1997 Feb;155:105-17
references.pmid: 9059886
references.citation: Bone Marrow Transplant. 2004 Oct;34(7):595-602
references.pmid: 15300228
references.citation: Nat Med. 2001 Sep;7(9):1052-6
references.pmid: 11533710
references.citation: J Exp Med. 1994 Apr 1;179(4):1285-95
references.pmid: 7908323
references.citation: Hematol J. 2000;1(2):136-44
references.pmid: 11920181
references.citation: J Exp Med. 2000 Dec 4;192(11):1637-44
references.pmid: 11104805
references.citation: Blood. 2004 Apr 15;103(8):3065-72
references.pmid: 15070686
references.citation: Br J Haematol. 2002 Jul;118(1):136-9
references.pmid: 12100138
references.citation: Haematologica. 1992 Mar-Apr;77(2):127-9
references.pmid: 1398297
references.citation: Br J Haematol. 2001 Jul;114(1):11-24
references.pmid: 11472339
references.citation: Nat Med. 2001 Sep;7(9):1057-62
references.pmid: 11533711
references.citation: Immunol Today. 1998 Apr;19(4):153-7
references.pmid: 9577090
references.citation: Br J Haematol. 2002 Jun;117(4):821-7
references.pmid: 12060116
references.citation: Blood. 2001 May 15;97(10):2923-31
references.pmid: 11342413
references.citation: J Immunol. 1998 Jun 1;160(11):5239-45
references.pmid: 9605119
references.citation: Nat Med. 1998 Mar;4(3):328-32
references.pmid: 9500607
references.citation: Blood. 2003 May 1;101(9):3730-40
references.pmid: 12511415
references.citation: Cancer. 1995 Sep 1;76(5):824-32
references.pmid: 8625186